(Patriot.Buzz) – In a significant legal maneuver for pro-life advocates, the attorneys general from Missouri, Idaho, and Kansas recently initiated a lawsuit against the Food and Drug Administration (FDA) and the U.S. Department of Health over their aggressive pro-abortion stance.

The suit alleges that these federal entities overstepped their legal boundaries over two decades ago when they sanctioned the use of abortion-inducing drugs. Furthermore, the suit challenges the legitimacy of permitting these pills to be delivered through postal services amidst the COVID-19 crisis.

The comprehensive 105-page legal filing in the U.S. District Court for the Northern District of Texas seeks an immediate prohibition on the distribution of abortion pills via mail. The suit suggests that this method of delivery could potentially aid sex traffickers and sexual predators in coercing victims to terminate pregnancies without detection by law enforcement.

Additionally, the plaintiffs demand the restoration of safety protocols that were relaxed in 2016 and call for the revocation of the FDA’s 2019 consent for a generic variant of the abortion medication.

The lawsuit articulates that the FDA has neglected its duty to ensure American safety by endorsing “risky, untested chemical abortion drugs.” It accuses the agency of prioritizing political agendas over scientific evidence and disregarding the consequent dangers, particularly to women and girls.

The FDA’s 2016 decision, which extends the permissible gestational period for using abortion drugs, decreases the number of mandated clinic visits, allows non-physicians to prescribe these medications, and removes the obligation to report certain adverse effects, is under scrutiny. Furthermore, in 2021, under the Biden administration, the FDA permitted the distribution of abortion pills through mail services.

A ruling by the Fifth Circuit Court of Appeals in August suggested that the challenge to the original FDA approval might be null due to the statute of limitations. However, the court also indicated that the FDA might have exceeded its remit when easing drug restrictions in 2016 and allowing mail distribution in 2021. Although this ruling is currently inoperative due to a Supreme Court stay, it underscores the ongoing legal contention surrounding the issue.

The recent suit argues that the FDA utilized an expedited approval process in 2000, dubiously categorizing pregnancy as an “illness” and claiming that abortion pills offered significant benefits over other abortion methods despite a lack of safety studies under prescribed usage conditions.

Before initiating the lawsuit, Bailey spearheaded a coalition of 20 states in cautioning pharmacies against compliance with the FDA’s guidelines on abortion pills, labeling the federal guidance as illegal and life-threatening. Bailey’s prepared statement underscored the belief that federal bureaucrats have overstepped their legal authority by endorsing the mail-order distribution of these “dangerous chemical abortion drugs.”